- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.6b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€215.40
7D
-1.0%
1Y
64.2%
UCB
Market Cap: €47.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€251.70
7D
0.7%
1Y
52.2%
argenx
Market Cap: €49.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€813.00
7D
7.6%
1Y
66.5%